Key Highlights

  • Marvell Technology (NASDAQ:MRVL) agreed on November 2, 2026 to buy Lumentum in an all-stock deal valued at an implied USD 115 billion enterprise value, at a fixed 4.500 Marvell shares per Lumentum share.
  • The terms imply about USD 1,132 per Lumentum share, a premium of about 23.9% to the unaffected October 28 close, with Marvell holders owning about 67% of the combined company.
  • Marvell identified more than USD 1 billion of annual run-rate cost synergies and expects non-GAAP EPS accretion in year one after closing, which is expected in the first half of 2028.
  • BofA cut Marvell to Neutral from Buy and its target to USD 225 from USD 400, citing roughly 50% share-count dilution, a long regulatory review and channel conflict.

What the Deal Looks Like

Marvell Technology (NASDAQ:MRVL) will pay entirely in stock, so no new financing is needed. Lumentum (NASDAQ:LITE) holders receive 4.500 Marvell shares each, and the company says the combination covers electrical and optical interconnect, switching, custom silicon, lasers, transceivers and optical circuit switching. Matt Murphy stays Chairman and CEO, and three Lumentum directors, including CEO Michael Hurlston, join a seven-member Marvell board. Closing needs both Shareholder votes, regulatory approvals and a Form S-4. Marvell cited an expanded addressable market of USD 550 billion, a company estimate. The aim is pre-validated, co-designed optical solutions that shorten customer time to market, and the deal adds Lumentum's indium phosphide and compound semiconductor Manufacturing capacity.

The Market Reaction

The reaction was sharp. Published market data showed Marvell down about 12.7% and Lumentum down about 18.6% on November 2, though Lumentum had risen 243% over the past year before the announcement and had fallen 21% in the prior week. BofA argued that USD 1 billion of cost savings would not offset the dilution, that Marvell sells chips to optical module makers that now compete with a Lumentum business, and that the deal surprised investors after the recent analyst day. B. Riley and Stifel cut Lumentum to Neutral and Hold, while Raymond James upgraded it with a USD 1,328 target and Mizuho held Outperform. The Philadelphia Semiconductor index had fallen 19% over the prior month, according to the BofA note, which shrank sector multiples before the announcement.

Risks and What to Watch

Lumentum reported fiscal first-quarter Revenue of USD 1.26 billion and EPS of USD 4.57, and guided December-quarter revenue to USD 1.60 billion and EPS to USD 6.05, so the target is growing fast. Because the exchange ratio is fixed, the value Lumentum holders receive moves with the Marvell share price, which has already fallen. A review that includes China, integration of two large engineering organizations and customer conflict are the main risks. Marvell also preliminarily reported fiscal third-quarter revenue and narrowed its guidance range to plus or minus 2%. Marvell Technology (NASDAQ:MRVL) is advised by Qatalyst, J.P. Morgan and Goldman Sachs. Legal counsel is Wilson Sonsini for Marvell and Davis Polk for Lumentum, and Citigroup and Evercore advise Lumentum.

Where Things Stand

Marvell Technology (NASDAQ:MRVL) is paying USD 115 billion because it wants to own optical lasers and transceivers as AI networks shift toward optical links, and management calls the opportunity once in a generation. Investors have punished the idea for now, with both stocks falling and several analysts downgrading on dilution and regulatory risk. The next milestones are the Form S-4, shareholder votes, regulatory reviews and Lumentum's December-quarter delivery. Fixed exchange ratios leave both sides exposed to the other's share price until closing.